Guilbault Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$611K Sell
2,336
-40
-2% -$10.3K 0.6% 43
2026
Q2
$598K Sell
2,376
-279
-11% -$60K 0.6% 38
2026
Q1
$577K Sell
2,655
-48
-2% -$10.6K 0.63% 36
2025
Q4
$618K Buy
+2,703
New +$616K 0.69% 34

Other funds holding ABBV

Guilbault Capital's ABBV Position: Q3 2026 in Review

Guilbault Capital reduced its AbbVie (ABBV) stake by 1.7% in Q3 2026, selling an estimated $10.3K and leaving 2,336 shares worth $611K. The position accounts for 0.6% of the portfolio, ranked #43.

Guilbault Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. The position peaked at $618K in Q4 2025. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Guilbault Capital held 2,336 shares of AbbVie worth $611K as of Q3 2026.
  • Guilbault Capital sold 40 AbbVie shares in Q3 2026, an estimated $10.3K.
  • AbbVie made up 0.6% of Guilbault Capital's portfolio in Q3 2026, its #43 holding.
  • Guilbault Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • Guilbault Capital's AbbVie position peaked at $618K in Q4 2025.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Guilbault Capital's 13F filing for Q3 2026, filed 28 Oct 2026.